|
FY2025
12 months to Dec 31, 2025
|
FY2024
11 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
7 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating expenses: | |||||
| Research and development | |||||
| Successor | |||||
| Total research and development | |||||
| General and administrative | |||||
| Successor | |||||
| Total general and administrative | |||||
| Franchise tax | |||||
| Operating expenses | |||||
| Successor | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Successor | |||||
| Total loss from operations | |||||
| Interest income earned on marketable securities held in Trust Account | |||||
| Loss before provision for income taxes | |||||
| Provision for income taxes | |||||
| Other income (expenses): | |||||
| Interest income, net | |||||
| Gain from settlement of liabilities with vendors | |||||
| Other income (expenses) | |||||
| Change in fair value of earnout liability and derivative liabilities | |||||
| Stock-based inducement expense | |||||
| Write off of deferred offering costs | |||||
| Interest income (expense), net | |||||
| Other income (expenses), net | |||||
| Successor | |||||
| Total other income (expenses), net | |||||
| Net loss | |||||
| Successor | |||||
| Predecessor | |||||
| Total net loss | |||||
| Deemed dividend on Series A, B and C Preferred Stock | |||||
| Deemed dividend on Series D Preferred Stock | |||||
| Deemed dividend on Series E Preferred Stock | |||||
| Deemed dividend - warrant pricing | |||||
| Deemed dividend related to Series C Common Warrants | |||||
| Successor | |||||
| Total deemed dividend related to Series C Common Warrants | |||||
| Deemed dividend – warrant repricing | |||||
| Net loss attributable to common shareholders | |||||
| Successor | |||||
| Total net loss attributable to common shareholders | |||||
| Net loss per common share: | |||||
| Basic (in Dollars per share) | |||||
| Class A Common Stock | |||||
| Class B Common Stock | |||||
| Successor | |||||
| Total basic (in Dollars per share) | |||||
| Diluted (in Dollars per share) | |||||
| Class A Common Stock | |||||
| Class B Common Stock | |||||
| Successor | |||||
| Total diluted (in Dollars per share) | |||||
| Weighted average common shares outstanding: | |||||
| Basic (in Shares) | |||||
| Class A Common Stock | |||||
| Class B Common Stock | |||||
| Successor | |||||
| Total basic (in Shares) | |||||
| Diluted (in Shares) | |||||
| Successor | |||||
| Total diluted (in Shares) | |||||
Loading...